⌘K

Login Start Free

Home/Filings/4/0000875320-24-000176

4//SEC Filing

Bozic Carmen 4

Accession 0000875320-24-000176

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:11 PM ET

Size

4.7 KB

Accession

0000875320-24-000176

Insider Transaction Report

Form 4

Period: 2024-06-12

VERTEX PHARMACEUTICALS INC / MAVRTX

EVP and CMO

Transactions

Sale
Common Stock
2024-06-12$478.00/sh−2,280$1,089,840→ 32,379 total

Footnotes (1)

[F1]Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024.

Documents

1 file

4
wk-form4_1718309487.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001790029

Filing Metadata

Form type: 4
Filed: Jun 12, 8:00 PM ET
Accepted: Jun 13, 4:11 PM ET
Size: 4.7 KB

View on SEC.gov